Big Boost With Third Vaccination: Antibody Response Against SARS-CoV-2 in Cancer Patients With B-cell Abnormalities
For those affected by B-cell cancer, a third SARS-CoV-2 vaccination is of particular importance. The 3rd vaccination often results in detectable antibody production even in those patients in whom the second vaccination has no effect and is therefore necessary for basic immunization. This recent study of the Karl Landsteiner University of Health Science has been published in the scientific journal "Cancers" and highlights that antibody levels increase quite generally significantly in almost all affected individuals after the 3rd vaccination. Overall, the work provides important insights for future vaccination strategies in a particularly vulnerable population – individuals suffering from cancer of cells that are important for the immune system.